Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > ROIV Roivant Sciences > Detailed Quotes

ROIV Roivant Sciences

Watchlist
7.800
+0.210+2.77%
Close  02/03 16:00 ET
7.626
-0.174-2.23%
Post Mkt Price 02/03 17:41 ET
High
8.275
Open
7.870
Turnover
71.69M
Low
7.715
Pre Close
7.590
Volume
9.01M
Market Cap
5.66B
P/E(TTM)
Loss
52wk High
10.000
Shares
725.42M
P/E(Static)
Loss
52wk Low
2.520
Float Cap
1.08B
Bid/Ask %
50.00%
Historical High
16.760
Shs Float
138.33M
Volume Ratio
4.55
Historical Low
2.520
Dividend TTM
--
Div Yield TTM
--
P/B
4.88
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
6.52%
Amplitude
7.38%
Avg Price
7.953
Lot Size
1
Float Cap
1.08B
Bid/Ask %
50.00%
Historical High
16.760
Shs Float
138.33M
Volume Ratio
4.55
Historical Low
2.520
Dividend TTM
--
P/B
4.88
Dividend LFY
--
Turnover Ratio
6.52%
Amplitude
7.38%
Avg Price
7.953
Lot Size
1
Price Forecast

News

Comment

Company Overview More
Roivant Sciences Ltd. engages in the biopharmaceutical business, which engages in the development of transformative medicine. Its product portfolio includes Vtama, Batoclimab, Brepocitinib, Namilumab, and RVT-2001, which aims to treat psoriasis, atopic dermatitis, thyroid eye disease, and other illnesses. The company was founded by Vivek Ramaswamy on April 7, 2014 and is headquartered in London, the United Kingdom.
CEO: Mr. Matthew Gline
Market: NASDAQ
Listing Date: 12/14/2020
Paper Trade More
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist